Boston, MA, – PAREXEL International Corporation (Nasdaq: PRXL) announced its strategic collaboration with Synchron Research Services Private Limited, a privately held contract research organization headquartered in Ahmedabad, India.
Under the alliance, PAREXEL will leverage Synchron’s capabilities to benefit bio/pharmaceutical clients with enhanced access to geographic coverage and multi-patient recruitment capabilities in India and Bangalore. The alliance also provides Synchron’s customers access to the clinical trial expertise and project management skills of PAREXEL, one of the world’s largest bio/pharmaceutical outsourcing providers. “The collaboration with Synchron expands our global clinical research services into regions that expedite drug development success for our clients,” said Josef H. von Rickenbach, PAREXEL’s Chairman and Chief Executive Officer. “Our alliance with an established company headquartered in India underscores PAREXEL’s commitment to providing clients with enhanced drug development services in emerging markets.”
“Through our alliance with PAREXEL, we can now offer clients an enhanced portfolio of clinical development solutions,” stated Dr. Shivprakash, M.Pharm, Ph.D., Chief Executive Officer, Synchron Research. “Our synergistic approach provides clients with enhanced clinical capabilities and strategies, enabling them to accelerate crucial time to market.”